The Impacts of Clinical Pharmacists’ Interventions on Clinical Significance and Cost Avoidance in a Tertiary Care University Hospital in Oman: A Retrospective Analysis
Authors:
- Juhaina Salim Al-MaqbaliJAJuhaina Salim Al-Maqbali
- Aqila TaqiATAqila Taqi
- Samyia Al-AjmiSASamyia Al-Ajmi
- Buthaina Al-HamadaniBAButhaina Al-Hamadani
- Farhat Al-HamadaniFAFarhat Al-Hamadani
- Fatima BahramFBFatima Bahram
- Kifah Al-BalushiKAKifah Al-Balushi
- Sarah GamalSGSarah Gamal
- Esra Al-LawatiEAEsra Al-Lawati
- Bushra Al SiyabiBSBushra Al Siyabi
- Ekram Al SiyabiESEkram Al Siyabi
- Nashwa Al-SharjiNANashwa Al-Sharji
Open Access
Abstract
Objectives: Pharmaceutical interventions are implicit components of the enhanced role that clinical pharmacists provide in clinical settings. We aimed to study the clinical significance and analyze the presumed cost avoidance achieved by clinical pharmacists’ interventions. Methods: A retrospective study of documented clinical pharmacists’ interventions at a tertiary care hospital in Oman was conducted between January and March 2022. The interventions were electronically recorded in the patients’ medical records as routine practice by clinical pharmacists. Data on clinical outcomes were extracted and analyzed. Cost implications were cross checked by another clinical pharmacist, and then, cost avoidance was calculated using the Rx Medi-Trend system values. Results: A total of 2032 interventions were analyzed, and 97% of them were accepted by the treating physicians. Around 30% of the accepted interventions were for antimicrobials, and the most common type was dosage adjustment (30%). Treatment efficacy was enhanced in 60% and toxicity was avoided in 22% of the interventions. The presumed cost avoided during the study period was USD 110,000 with a projected annual cost avoidance of approximately USD 440,000. Conclusion: There was an overall positive clinical and financial impact of clinical pharmacists’ interventions. Most interventions have prevented moderate or major harm with a high physician acceptance rate. Optimal documentation of the interventions is crucial for emphasizing clinical pharmacists’ value in multi-specialty hospitals.Keywords
This publication has 26 references indexed in Scilit:
- Drug Errors and Related Interventions Reported by U nited S tates Clinical Pharmacists: The A merican C ollege of C linical P harmacy P ractice‐ B ased R esearch N etwork M edication E rror D etection, A melioration and P revention StudyPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013
- Postdischarge pharmacist medication reconciliation: Impact on readmission rates and financial savingsJournal of the American Pharmacists Association, 2013
- The impact of HIV clinical pharmacists on HIV treatment outcomes: a systematic reviewPatient Preference and Adherence, 2012
- The Economic Burden of Inappropriate Drug Prescribing, Lack of Adherence and Compliance, Adverse Drug Events in Older PeopleDrug Safety, 2012
- Analysis of enquiries to the National Pharmacy Association following major changes to controlled drug legislation in the UKInternational Journal of Pharmacy Practice, 2011
- Impact of Pharmacist Care in the Management of Cardiovascular Disease Risk FactorsArchives of internal medicine (1960), 2011
- Evaluation and justification of clinical pharmacy servicesExpert Review of Pharmacoeconomics & Outcomes Research, 2009
- Pharmacist Involvement in Improving Asthma Outcomes in Various Healthcare Settings: 1997 to PresentAnnals of Pharmacotherapy, 2009
- The Impact of Clinical Pharmacists on Drug‐Related Problems and Clinical OutcomesBasic & Clinical Pharmacology & Toxicology, 2008
- Cost implications of and potential adverse events prevented by interventions of a critical care pharmacistAmerican Journal of Health-System Pharmacy, 2007